Fusion event
HBV-DIO2-AS1 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTTACTGGGCTTTATTCTTCTACTGTACCTGTCTTTAATCCTCATTGGAAAACACCATCTTTTCCTAATATACATTTACACCAAGACATTATCAAAAAAT| |GTGAACAGTTTGTAGGCCCACTCACAGTTAATGAGAAAAGAAGATTGCAATTGATTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATT
End
80728588/80262245 (Hg38)
Location type
ncRNA_intronic
Nearest miRNA
hsa-mir-1260a/Upstream/2995955; hsa-mir-1185-1/Downstream/13685981;
Upstream sequence
tttagtagatgaggtttcactatgttgccaaggctggtcatgaactcctgggctcaagcaatcctctgccttggcctcccaaagtgctggaattataagt
Downstream sequence
gtgagctatcatgcctagccAAAATCCTAAAGATTCTTTAGCACTTAGCTGAATTGTCACTTCTAGAAAGCTGTAGAAAGCCTAAATGTCTCTCTCCTAC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.